COVID-19 Drug Research


SARS-CoV-2 has been set apart as an exceptionally pathogenic virus of COVID-19 sickness, causing over huge millions of cases and deaths still recording around the world. In spite of the fact that there are no particular antiviral treatments that have demonstrated viability in randomized clinical preliminaries. The worldwide foundations and pharmaceuticals have started to parse out compelling immunizations for the counteraction of COVID-19.



 


  • Solidarity- Clinical trial
  • Veklury (Remdesivir)
  • REGEN-COV (Casirivimab and Imdevimab)
  • Sotrovimab
  • Bamlanivimab and Etesevimab
  • Generic Drug Applications

Related Conference of COVID-19 Drug Research

November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
December 01-02, 2025

13th International Conference on Clinical Trials

Vancouver, Canada
January 29-30, 2026

19th World Drug Delivery Summit

Paris, France
February 10-11, 2026

40th World Congress on Pharmacology and Therapeutics

Barcelona, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy

COVID-19 Drug Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in